Compound 570
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1N(=O)=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCC(CC1)NC(=O)c1ccccc1-c1ccc(Cl)cc1
- IUPAC name:
2-(4-chlorophenyl)-N-[1-[4-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylcarbamoyl]phenyl]piperidin-4-yl]benzamide
- InChi:
InChI=1S/C43H45ClN6O6S2/c1-48(2)25-22-34(29-57-36-8-4-3-5-9-36)45-40-21-20-37(28-41(40)50(53)54)58(55,56)47-42(51)31-14-18-35(19-15-31)49-26-23-33(24-27-49)46-43(52)39-11-7-6-10-38(39)30-12-16-32(44)17-13-30/h3-21,28,33-34,45H,22-27,29H2,1-2H3,(H,46,52)(H,47,51)/t34-/m1/s1
- InChiKey:
MDBZEHHWABLHNZ-UUWRZZSWSA-N
External links
42601768 |
External search
Bibliography (1)
Publication | Name |
---|---|
Haixiao Zhai, Xiong Cai, Curis, Inc.. . Bcl-2 inhibitors None. | 10 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.30 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 840.25 g/mol | |||
HBA | 12 | |||
HBD | 3 | |||
HBA + HBD | 15 | |||
AlogP | 6.69 | |||
TPSA | 156.67 | |||
RB | 15 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009036035 | 10 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.30 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5353 | Navitoclax | DB12340 | |
0.4636 | Venetoclax | DB11581 | |
0.4107 | Nelfinavir | DB00220 | |
0.4098 | Clorexolone | DB13617 | |
0.4089 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
0.4054 | Quinethazone | DB01325 | |
0.4052 | TAK-901 | DB12756 | |
0.4011 | Sulfabenzamide | DB09355 | |
0.3957 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.3948 | Anatibant | DB05038 | |
0.3942 | Repinotan | DB06506 | |
0.3937 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.3879 | ABT-639 | DB15055 | |
0.3872 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
0.3857 | [4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone | DB01836 |